Formulation Development

FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES

FORMULATION DEVELOPMENT APPLICATIONS & STUDIES

FORMULATION DEVELOPMENT PRODUCTS & SERVICES

Fluorescent Stereo Microscope Leica M165 FC

The Leica M165 FC fully apochromatic corrected stereo microscope with 16.5:1 zoom optics resolves structures down to 1.1 micron for detailed fluorescent imaging.

Image coding allows easy, convenient reproduction of image settings and parameters for fast, consistent, high quality observation and documentation.

TripleBeam technology dedicates a separate beam channel for fluorescence illumination to enhance image contrast, details and intensity for better performance.

Uniquely Ergonomic System Microscopes With Intelligent Automation Leica DM3000 LED

Enhance Laboratory Workflow

The Leica DM3000 LED microscopes for pathology, cytology, haematology and many other applications feature a motorized nosepiece, condenser head, automated light intensity adjustment, and optional foot pedal. These intuitive microscopes improve workflows significantly. For special diagnostics requirements, the microscope is certified for in-vitro-diagnostics (IVD) like in-vitro-fertilization (IVF).

Used Carl Zeiss Microscope, with AxioCam MRc5 and H.I.P controls, CE design, serial# 39180008000.

Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.

Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation and analytical development for both highly potent and non-potent drug products.

Optimize Your GC Analysis with Zebron GC Columns

Zebron GC columns are engineered with quality of analysis in mind to better support scientists' research and regulatory analysis for environmental, food safety, food quality, forensics, pharma, fuels, and specialty chemicals.

When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.